WHO: New invitation for expression of interest to manufacturers of antituberculosis medicines

To support national and global efforts to increase access to and the affordability of TB care and treatment, the World Health Organization (WHO), together with UNICEF, UNAIDS and Unitaid, invites manufacturers of selected pharmaceutical products to submit expressions of interest for product evaluation to the WHO Prequalification Unit.

For detailed information, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By World Health Organization

Published: July 5, 2021, 2:38 a.m.

Last updated: July 15, 2021, 10:25 p.m.

Tags: Treatment, Access

Print Share